Brief: Genor Biopharma Posts HY Adjusted Loss RMB380.7 Million
30/08/2022 15:59
Aug 30 (Reuters) - Genor Biopharma Holdings Ltd 6998.HK :
* HY ADJUSTED LOSS RMB380.7 MILLION VERSUS LOSS RMB293.5
MILLION
* HY TOTAL REVENUE RMB3.0 MILLION
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman